Allergan has withdrawn textured breast implants from the market.
The move follows increased scrutiny on textured breast implants and their connection to BIA-ALCL, an uncommon lymphoma that can develop around breast implants. The U.S. Food and Drug Administration (FDA) requested that Allergan withdraw specific models of its textured breast implants from the market due to the risk of BIA-ALCL, and Allergan agreed to voluntarily issue the withdrawal as a precautionary measure.
The current advice to patients with these types of implants is that no action is required.
A full statement has been issued by the British Association of Plastic Surgeons (BAAPS) and can be found here.
If you have any concerns regarding your breast implants or would like to discuss further, please contact our office on 0131 316 2459 and we will be more than happy to help.
